CBSET appoints Michael Naimark as director
CBSET, a preclinical research company, announced that it has appointed Michael Naimark as director of business development.READ MORE Debenhams appoints Stephen J. Ingham as non-executive director
Most recently, Mr. Naimark was employed by the Neural Stem Cell Institute (NSCI) as project manager overseeing the development of a cell-based therapy for macular degeneration under a 4-year award from the New York Stem Cell Foundation.
Previously, Mr. Naimark was co-owner of Care Research, a preclinical research organization where he provided operational, sales, and marketing oversight as Director of Surgical Models.
Prior to founding Care Research, Mr. Naimark helped launch Preclinical Research Services Inc., a preclinical research organization, and served as senior study director for several years.
